MIRA INFORM REPORT

 

 

Report Date :

10.12.2013

 

IDENTIFICATION DETAILS

 

Name :

UNIJULES LIFE SCIENCES LIMITED

 

 

Registered Office :

Shop No. 41, Manisha Plaza, Sonapur Lane, Off LBS Marg, Kurla (West), Mumbai – 400072, Maharashtra

 

 

Country :

India

 

 

Financials (as on) :

31.03.2012

 

 

Date of Incorporation :

16.01.2006

 

 

Com. Reg. No.:

11-158928

 

 

Capital Investment / Paid-up Capital :

Rs. 138.637 Millions

 

 

CIN No.:

[Company Identification No.]

U52311MH2006PLC158928

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

MUMU04752G

 

 

PAN No.:

[Permanent Account No.]

AAACU8032D

 

 

Legal Form :

A Closely Held Public Limited Liability Company

 

 

Line of Business :

Manufacturer of Pharmaceuticals.

 

 

No. of Employees :

Information denied by management

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (50)

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 4600000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having a satisfactory track record.

 

Management of the company has failed to file its financial for the year 2013 with the government department.

 

As per available, we found that the company has achieved better growth in its turnover during 2012. Networth of the company appears to be decent.

 

Trade relations are fair. Business is active. Payment terms are usually correct.

 

The company can be considered for business dealings at usual trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – March 31st, 2013

 

Country Name

Previous Rating

(31.12.2012)

Current Rating

(31.03.2013)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

INDIAN ECONOMIC OVERVIEW

 

The current downturn provides an opportunity to push ahead with reforms to accelerate growth, says the latest India Development Update report released by the World Bank. The report says that the adverse effects of rupee depreciation are likely to be offset by the gains in the exports performance due to improved external competitiveness. Since May this year, the local currency has depreciated substantially and fell to a record level of Rs 68.85 to a dollar on August, 28.

 

A stagflation like situation appears to have arisen as inflation jumped to an eight month high of 6.46 % for the month of September. It is up from 6.10 % in August. Growth continues to be muted with factory output plunging to 0.6  % in August. Onion prices have risen nearly 300 % from last September. Vegetables cost nearly 90 % more than they did last year. Wake up to the economic contribution of slum dwellers. They contribute more than 7.5 % to the country’s gross domestic product, according to a recent study conducted in 50 top cities.

 

136000 estimated number of jobs created during the second quarter of the current financial year. 50000 estimated number of additional jobs in the field of corporate social responsibility in the coming years.

 

The International Finance Corporation expects to come out with its rupee linked bonds issue before the end of 2013 as a part of its plan to raise $ 1 billion. The Apple iPhone 5c (Rs 41900 for 16 GB variant) and 5s (Rs 53500 for 16GB variant) has been launched in India from 1st November.

 

The Land Acquisition Act to provide just and fair compensation to farmers will come into force from January 1 next year, said Rural Development Minister Jairam Ramesh. The Act replaces a 119 year old registration. The Securities and Exchange Board of India has approved the trading of currency futures on the Bombay Stock Exchange. The exchange plans to launch the currency futures platform with advanced trading technology by the end of November.

 

 

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

CRISIL

Rating

Long Term Rating = BBB-

Rating Explanation

Having moderate degree of safety and carry moderate credit risk. 

Date

24.07.2012

 

Rating Agency Name

CRISIL

Rating

Short Term Rating = A3

Rating Explanation

Moderate degree of safety and higher credit risk. 

Date

24.07.2012

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2012.

 

INFORMATION DECLINED BY

 

Name :

Mr. Jagdish Gupta

Designation :

Account Department  

Date :

09.12.2013

 

 

LOCATIONS

 

Registered Office :

Shop No.41, Manisha Plaza, Sonapur Lane, Off LBS Marg, Kurla (West), Mumbai – 400072, Maharashtra, India

Tel. No.:

91-22-25035173

Fax No.:

Not Available

E-Mail :

unijulesbom@yahoo.co.in

info@unijules.com

alihatimh@gmail.com

compliance@unijules.com

Website :

www.unijules.com

Location :

Owned

 

 

Corporate Office / Factory:

B – 35 and 36, MIDC Industrial Area, Kalmeshwar. District Nagpur - 441501, Maharashtra, India

Tel. No.:

91-7118-271010

Fax No.:

91-7118-272522

 

 

DIRECTORS

 

As on 29.09.2012

 

Name :

Mr. Faiz Zakir Vali

Designation :

Managing Director

Address :

Universal Pharmacy, Plot No. 545, Shantinagar, Nayapura , Nagpur - 440002 Maharashtra, India

Date of Birth/Age :

25.02.1967

Qualification :

MBA. B Pharm

Date of Appointment :

25.09.2010

PAN No.:

ABBPV9750E

DIN No.:

01809196

 

 

Name :

Mr. Dharampal Keshawdas Bellani

Designation :

Whole Time Director

Address :

Block No. 371/B, Gurunanak Nagar, Jaripatka, Nagpur - 440014, Maharashtra, India

Date of Birth/Age :

30.04.1956

Qualification :

B. Pharm

Date of Appointment :

25.09.2010

PAN No.:

ABNPB0886F

DIN No.:

01824596

 

 

Name :

Mr. Gulam Abbas Hassonjee

Designation :

Director

Address :

202, Radhe Apartment, Mecosabagh, Clark Town, Nagpur – 440004, Maharashtra,  India

Date of Birth/Age :

13.04.1941

Date of Appointment :

30.09.2013

DIN No.:

00162445

 

 

Name :

Mr. Rajeev Kawaduji Jidewar

Designation :

Whole-time director

Address :

10, Nandanvan Colony, Nagpur – 440009, Maharashtra, India 

Date of Birth/Age :

03.10.1956

Date of Appointment :

30.09.2013

DIN No.:

00450038

 

 

KEY EXECUTIVES

 

Name :

Ms. Shilpa Pawankar

Designation :

Company Secretary

Address :

Plot No. 12, Adarsh Wadi, Amaravati Road, Nagpur – 440023, Maharashtra,  India

Date of Birth/Age :

12.06.1986

Date of Appointment :

12.01.2010

Pan No.:

BDSPP0606B

 

 

Name :

Mr. Jagdish Gupta

Designation :

Account Department  

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on 29.09.2012

 

Names of Shareholders

 

No. of Shares

Faiz Zakir Vali

 

8313684

Nitish Shastri

 

2000

Esa Mohammad Vali

 

2000

Shehrebano Vali

 

2000

Rajeev Jidewar

 

2000

Sharmishtha U. Khobragade

 

2000

Astra Exim Private Limited, India

 

2225500

Benzo Petro International Limited, India

 

468750

Virtuous Capital Limited (Formally known as Finaventure Advisory Services (India) Limited), India

 

2781200

Pranav Financial Services Private Limited, India 

 

64516

Total

 

13863650

 

As on 29.09.2012

Equity Share Break up (Percentage of Total Equity)

 

Category

Percentage

Bodies corporate

                     39.96

Directors or relatives of Directors

60.00

Other top fifty shareholders

0.04

Total

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of Pharmaceuticals.

 

 

Products :              

ITC Code

Product Description

30049056

Quinine Injections

 

PRODUCTION STATUS (AS ON 31.03.2011)

 

Particulars

Unit

Actual Production

Allopathic :

 

 

Liquid (in 000)

Ltrs

3590191.70

Ointment

Kgs.

70163.72

Powder

Kgs.

8379.35

Capsulses ('000)

Nos.

10476.71

Injection :

 

 

Vials/ Ampoules

Nos

56871415.00

Herbal :

 

 

Liquid

Ltrs

437100.79

Tablets ('000)

Nos.

82037.16

Capsulses ('000)

Nos.

71590.77

Powder

Kgs.

2243211.02

 

 

GENERAL INFORMATION

 

No. of Employees :

Information denied by management

 

 

Bankers :

·         Punjab National Bank, MID Corporate Branch, Suryanagar, Nagpur - 440035, Maharashtra, India

 

·         Axis Bank Limited, Ground Floor, Atlanta Building, Nariman Point, Mumbai - 400021, Maharashtra, India

 

·         Allahabad Bank, Civil Lines, Nagpur - 440001, Maharashtra, India

 

·         Bank of Maharashtra, Mid Corporate Branch, Mahabank Bhavan, Sitabuldi, Nagpur - 440012, Maharashtra, India

 

·         Yes Bank Limited, 9th Floor, Nehru Centre, Discovery Of India, Dr. Annie Besant Road, Worli, Mumbai - 400018, Maharashtra, India

 

·         State Bank of India, Industrial Finance Branch, World Trade Centre, Cuffe Parade, Mumbai - 400005, Maharashtra, India

 

·         The Shamrao Vithal Co-Operative Bank Limited, 39, Vrinda Kunj, Matamandir Road, Dharampeth, Nagpur - 440010, Maharashtra, India

 

·         Indusind Bank, Mumbai

·         HSBC BANK

·         Union Bank of India

·         Bank of Baroda

·         ICICI Bank Limited

 

 

Facilities :

(Rs. In Millions)

Secured Loan

As on

31.03.2012

As on

31.03.2011

Long-term borrowings

 

 

Rupee term loans from banks

295.345

284.444

Other loans and advances

3.288

2.009

Short-term borrowings

 

 

Loans repayable on demand from banks

(Hypothecation of Raw Material, Packing Material, Work In Progress, Finished Goods and Book Debts)

966.131

642.782

Other loans and advances

(Fixed Assets and Bank Gaurantee)

52.191

130.139

Total

1316.955

1059.374

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

Husain Ali Hatim Shabbir

Chartered Accountants

Address :

315 B Ashirwad Complex, Ramdaspeth, Nagpur – 440012, Maharashtra, India

Tel. No.:

91-712-2420204

Fax No.:

91-712-2420204

PAN.:

ABCPH6547G

 

 

Subsidiaries :

RevAyur Beauty Care India Private Limited

CIN No.: U93090MH2009PTC196258

 

 

Associates :

·         Akasa Advertisement

·         Universal Pharmacy

·         City Pharmacy

·         Saif Health Remedies Private Limited

 

 

CAPITAL STRUCTURE

 

As on 29.09.2012

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

25000000

Equity Shares

Rs.10/- each

Rs.250.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

13863650

Equity Shares

Rs.10/- each

Rs.138.637 Millions

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

 

31.03.2012

31.03.2011

I.        EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

 

138.637

138.637

(b) Reserves & Surplus

 

1035.832

693.413

(c) Money received against share warrants

 

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

 

0.000

0.000

Total Shareholders’ Funds (1) + (2)

 

1174.469

832.050

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

 

298.633

286.453

(b) Deferred tax liabilities (Net)

 

53.887

23.384

(c) Other long term liabilities

 

0.000

0.000

(d) long-term provisions

 

11.244

7.893

Total Non-current Liabilities (3)

 

363.764

317.730

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

 

1063.870

800.867

(b) Trade payables

 

444.327

342.789

(c) Other current liabilities

 

1.536

0.000

(d) Short-term provisions

 

0.000

0.000

Total Current Liabilities (4)

 

1509.733

1143.656

 

 

 

 

TOTAL

 

3047.966

2293.436

 

 

 

 

II.      ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

 

844.407

428.333

(ii) Intangible Assets

 

2.674

2.308

(iii) Capital work-in-progress

 

34.824

157.833

(iv) Intangible assets under development

 

0.000

0.000

(b) Non-current Investments

 

19.230

33.636

(c) Deferred tax assets (net)

 

0.000

0.000

(d)  Long-term Loan and Advances

 

0.000

0.000

(e) Other Non-current assets

 

0.000

0.000

Total Non-Current Assets

 

901.135

622.110

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

 

0.000

0.000

(b) Inventories

 

373.044

308.766

(c) Trade receivables

 

1337.953

1071.959

(d) Cash and cash equivalents

 

28.464

103.651

(e) Short-term loans and advances

 

388.060

171.652

(f) Other current assets

 

19.310

1.298

Total Current Assets

 

2146.831

1657.326

 

 

 

 

TOTAL

 

3047.966

2293.436

 


 

SOURCES OF FUNDS

 

 

 

31.03.2010

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

 

 

138.637

2] Share Application Money

 

 

0.000

3] Reserves & Surplus

 

 

481.935

4] (Accumulated Losses)

 

 

0.000

NETWORTH

 

 

620.572

LOAN FUNDS

 

 

 

1] Secured Loans

 

 

211.348

2] Unsecured Loans

 

 

1.378

TOTAL BORROWING

 

 

212.726

DEFERRED TAX LIABILITIES

 

 

20.303

 

 

 

 

TOTAL

 

 

853.601

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

 

 

298.132

Capital work-in-progress

 

 

38.089

 

 

 

 

INVESTMENT

 

 

30.616

DEFERREX TAX ASSETS

 

 

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

 
 

304.922

 

Sundry Debtors

 
 

694.667

 

Cash & Bank Balances

 
 

16.270

 

Other Current Assets

 
 

0.000

 

Loans & Advances

 
 

279.545

Total Current Assets

 
 

1295.404

Less : CURRENT LIABILITIES & PROVISIONS

 
 

 

 

Sundry Creditors

 
 

193.828

 

Other Current Liabilities

 
 

537.044

 

Provisions

 
 

78.863

Total Current Liabilities

 
 

809.735

Net Current Assets

 
 

485.669

 

 

 

 

MISCELLANEOUS EXPENSES

 

 

1.095

 

 

 

 

TOTAL

 

 

853.601

 


PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2012

31.03.2011

31.03.2010

 

SALES

 

 

 

 

 

Income

3668.373

2661.848

1982.636

 

 

Other Income

72.581

27.418

1.138

 

 

TOTAL                                    

3740.954

2689.266

1983.774

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Cost of materials consumed

2989.871

2243.364

1530.006

 

 

Changes in inventories of finished goods, work-in-progress and stock-in-trade

(55.435)

(113.264)

38.003

 

 

Employee benefit expense

93.142

46.528

98.552

 

 

Other expenses

134.626

107.447

3.586

 

 

Exceptional items

(64.826)

0.000

 

 

 

TOTAL                                    

3097.378

2284.075

1688.862

 

 

 

 

 

Less

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION

643.576

405.191

294.912

 

 

 

 

 

Less

FINANCIAL EXPENSES                        

149.642

89.283

71.424

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION

493.934

315.908

223.488

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                    

23.177

16.003

11.219

 

 

 

 

 

 

PROFIT BEFORE TAX

470.757

299.905

212.178

 

 

 

 

 

Less

TAX                                                                 

128.338

88.428

86.014

 

 

 

 

 

 

PROFIT AFTER TAX

342.419

211.477

126.164

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

512.949

301.472

175.308

 

 

 

 

 

 

BALANCE CARRIED TO THE B/S

855.368

512.949

301.472

 

 

 

 

 

 

Earnings Per Share (Rs.)

24.70

15.26

9.39

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2012

31.03.2011

31.03.2010

PAT / Total Income

(%)

9.15

7.86

6.36

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

12.83

11.27

10.70

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

15.72

14.36

13.31

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.40

0.36

0.34

 

 

 

 

 

Debt Equity Ratio

(Total Debt /Networth)

 

1.16

1.31

0.34

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.42

1.45

1.60

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

Yes

9]

Name of person contacted

Yes

10]

Designation of contact person

Yes

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

----------------------

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

No

20]

Export / Import details (if applicable)

No

21]

Market information

----------------------

22]

Litigations that the firm / promoter involved in

----------------------

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

----------------------

26]

Buyer visit details

----------------------

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC          

No

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

Yes

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

Yes

 

 

YEAR IN RETROSPECT:

 

The company has repeated its winning streak of clocking 37.79% incremental growth in the last year’s. The Company has achieved a total sale of Rs.3665.390 Millions (net of excise) as against Rs.2660.030 Millions (net of excise) for the same period in the last year. The Company has achieved a net profit of Rs.342.419 Millions (After provision of tax) as against Rs.211.477 Millions for the same period in the last year registering an increase of 61.80%.

 

 

BUSINESS OUTLOOK:

 

Some of the major milestones crossed during the year were,

 

INSTITUTIONAL BUSINESS remains a major thrust area looking to the huge national budget and the company’s historical expertise in this segment. During the year, we successfully participated in bulk tenders to cater to increased capacities thereby achieving the targeted growth milestones.

 

RESEARCH AND DEVELOPMENT infrastructure was recognized as PhD Centre by the university which opens the gate way for doing the best research and retaining the best researchers in the company thus generating the new technologies and the products.

 

THE INTELLECTUAL PROPERTY INITIATIVE resulted in filing of 24 filled patents which are under different stages of the evaluation by the WIPO. These patents include various progress done on standardization of herbal and Ayurvedic plants and formulations

 

PUBLISHED 10 research papers in this year in different national and international journals which is proving to help us in registration of these products in different countries.

 

Overall INTERNATIONAL FOOTPRINT increased to cover ASEAN, CIS and neighboring countries with various dossiers filed for registration. Commercialized more than 80 products which found its reach in different countries.

 

On the PRODUCT PIPELINE FRONT, development work progressed as per plan on the technologies related to NDDS. Further, new technologies identified and the work started on like cooling gel sheets, liquid in hard gelatin capsule forms.

 

The CLINICAL TRIALS of 4 of our herbal products will be completed in October, 2012. Good work done in the field of herbal remedy for sickle cell anemia with on field trials under progress.

 

ETHICAL SALES DIVISION increased its footprint in existing states by increasing the number of Head Quarters and Field force resulting in increase of 75 % over last year. Addition of Novel high margin products increased the overall yield from this segment. REVAYUR continues on its growth trajectory by sing novel ways of brand development including a tie up with FEMINA group for publicity. The number of different SKU’s also increased to cover the professional Beauty parlors as well as launch of a Hair Care range of Products. There is increased interest for this beauty care range on the international front and will be a key result area in the coming years. HERBULES product range continues to expand almost doubling the sales. Current plans are to increase the market reach of this range of products. Tremendous response for these products from Bangladesh, CIS and UAE markets.

 

On the management and infrastructure front,

 

Integrated common ERP platform has been successfully implemented on line across all locations resulting in improved reporting and efficiency in operations. Combined H.R. department established for uniform implementation of policies across the group. New herbal facility attained full commercial production resulting in increased revenues from the herbal segment. Efficiency audits conducted at the injectable plant thus improving productivity by 23 % without any capital expenses.

 

 

UNSECURED LOAN

Rs. In Millions

Particular

As on

31.03.2012

As on

31.03.2011

Short-term borrowings

 

 

Loans repayable on demand from others

9.898

0.000

Loans and advances from others

35.650

27.946

Total

45.548

27.946

 

 

 

 

 

INDEX OF CHARGES

 

S.No.

Charge ID

Date of Charge Creation/Modification

Charge amount secured

 

Charge Holder

Address

Service Request Number (SRN)

1

10427281

26/03/2013

480,000,000.00

PUNJAB NATIONAL BANK

MID CORPORATE BRANCH, SURYANAGAR, NAGPUR, MAHARASHTRA - 440035, INDIA

B75672410

2

10376918

17/09/2012

100,000,000.00

YES BANK LIMITED

9TH FLOOR, NEHRU CENTRE, DISCOVERY OF INDIA, DR. ANNIE BESANT ROAD, WORLI, MUMBAI, MAHARASHTRA - 
400018, INDIA

B58276841

3

10377122

16/11/2012 *

430,000,000.00

BANK OF MAHARASHTRA

MID CORPORATE BRANCH, MAHABANK BHAVAN, SITABULDI, 
NAGPUR, MAHARASHTRA - 440012, INDIA

B62804463

4

10356491

28/03/2012

42,500,000.00

STATE BANK OF INDIA

INDUSTRIAL FINANCE BRANCH, WORLD TRADE CENTRE, CUFFE PARADE, MUMBAI, MAHARASHTRA - 400005, INDIA

B39904537

5

10351320

02/03/2012

400,000.00

STATE BANK OF INDIA

ITWARI BRANCH, NAGPUR, MAHARASHTRA - 440002, INDIA

B38055968

6

10332807

03/04/2012 *

297,900,000.00

STATE BANK OF INDIA

INDUSTRIAL FINANCE BRANCH, WORLD TRADE CENTRE, CUFFE PARADE, MUMBAI, MAHARASHTRA - 400005, INDIA

B39917398

7

10327684

03/04/2012 *

1,101,000,000.00

STATE BANK OF INDIA

INDUSTRIAL FINANCE BRANCH, WORLD TRADE CENTRE, CUFFE PARADE, MUMBAI, MAHARASHTRA - 400005, INDIA

B39917034

8

10318293

05/11/2011

350,000.00

THE SHAMRAO VITHAL CO-OPERATIVE BANK LIMITED

SVC TOWER, NEHRU ROAD, VAKOLA, SANTACRUZ (EAST), 
MUMBAI, MAHARASHTRA - 400055, INDIA

B25572587

9

10318325

22/10/2011

622,000.00

THE SHAMRAO VITHAL CO-OPERATIVE BANK LIMITED

SVC TOWER, NEHRU ROAD, VAKOLA, SANTACRUZ (EAST), 
MUMBAI, MAHARASHTRA - 400055, INDIA

B25580515

10

10313419

05/10/2011

715,000.00

SHAMRAO VITHAL CO-OPERATIVE BANK LIMITED

SVC TOWER, NEHRU ROAD, VAKOLA, SANTACRUZ (EAST), 
MUMBAI, MAHARASHTRA - 400055, INDIA

B23625031

11

10305188

19/07/2011

300,000,000.00

BANK OF BARODA

CORPORATE FINANCIAL SERVICES BRANCH, MANTRI COURT, 1ST FLOOR, 39 RAMABAI AMBEDKAR ROAD, PUNE, MAHARASHTRA - 411001, INDIA

B20021085

12

10290108

25/02/2013 *

322,500,000.00

ALLAHABAD BANK

CIVIL LINES,, NAGPUR, MAHARASHTRA - 440001, INDIA

B76666726

13

10273049

04/02/2011

41,600,000.00

STATE BANK OF INDIA

ITWARI BRANCH, ITWARI, NAGPUR, MAHARASHTRA - 440002, INDIA

B07059652

14

10273029

04/02/2011

692,500,000.00

STATE BANK OF INDIA

ITWARI BRANCH, ITWARI, NAGPUR, MAHARASHTRA - 4400 
02, INDIA

B06939730

15

10307948

25/01/2011

692,500,000.00

STATE BANK OF INDIA

ITWARI BRANCH, ITWARI, NAGPUR, MAHARASHTRA - 440002, INDIA

B09530320

16

10346163

22/11/2010

317,000.00

THE SHAMRAO VITHAL CO-OPERATIVE BANK LIMITED

39, VRINDA KUNJ, MATAMANDIR ROAD, DHARAMPETH, NAGPUR, MAHARASHTRA - 440010, INDIA

B30914006

17

10346161

11/11/2010

1,462,400.00

THE SHAMRAO VITHAL CO-OPERATIVE BANK LIMITED

39, VRINDA KUNJ, MATAMANDIR ROAD, DHARAMPETH, NAGPUR, MAHARASHTRA - 440010, INDIA

B30912802

18

10234487

31/05/2010

872,500,000.00

AXIS BANK LIMITED

UNIT NO 6 ,CREDIT MANAGEMENT CENTRE, CORPORATE PARK, CHEMBUR, MUMBAI, MAHARASHTRA - 400071, INDIA

A89810055

19

10294689

31/03/2010

180,000,000.00

STATE BANK OF INDIA

ITWARI BRANCH, NAGPUR, MAHARASHTRA - 440002, INDIA

A92558139

20

10169305

31/05/2010 *

680,302,000.00

AXIS BANK LIMITED

UNIT NO 6 ,CREDIT MANAGEMENT CENTRE, CORPORATE PARK, CHEMBUR, MUMBAI, MAHARASHTRA - 400071, INDIA

A89811087

21

10164122

21/01/2010 *

552,500,000.00

AXIS BANK LIMITED

GROUND FLOOR,ATLANTA BLD, NARIMAN POINT, MUMBAI,  MAHARASHTRA - 400021, INDIA

A80677834

22

10121132

31/07/2008

440,302,000.00

THE SHAMRAO VITHAL CO-OP. BANK LIMITED.

YAMUNA SADAN, SAKI VIHAR ROAD, SAKINAKA, ANDHERI 
(EAST), MUMBAI, MAHARASHTRA - 400072, INDIA

A45172210

23

10072672

31/07/2008 *

440,302,000.00

THE SHAMRAO VITHAL CO-OP. BANK LIMITED.

YAMUNA SADAN, SAKI VIHAR ROAD,, SAKINAKA, ANDHERI 
(EAST), MUMBAI, MAHARASHTRA - 400072, INDIA

A45171758

24

10074903

04/09/2006

27,050,000.00

THE SHAMRAO VITHAL CO-OP. BANK LIMITED.

YAMUNA SADAN, SAKI VIHAR ROAD, SAKINAKA, ANDHERI  (EAST), MUMBAI, MAHARASHTRA - 400072, INDIA

A08154445

25

80017269

31/07/2008 *

440,302,000.00

THE SHAMRAO VITHAL CO-OP. BANK LIMITED.

YAMUNA SADAN, SAKI VIHAR ROAD,, SAKINAKA, ANDHERI 
(EAST), MUMBAI, MAHARASHTRA - 400072, INDIA

A45190766

 

* Date of charge modification

 

 

FIXED ASSETS

 

·         Land

·         Factory Building

·         Plant and Machinery

·         AHU

·         Electric Installation

·         Laboratory Equipments

·         Office Equipments

·         Computer Accessories

·         E.P.A.B.X.

·         Vehicles

·         Furniture and Fixture

·         Borwell

·         Canteen Utensils

·         Trade Mark

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                              None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.61.18

UK Pound

1

Rs.100.01

Euro

1

Rs.83.82

 

 

INFORMATION DETAILS

 

Information Gathered by :

SVA

 

 

Report Prepared by :

NTH

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

4

PAID-UP CAPITAL

1~10

4

OPERATING SCALE

1~10

6

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

6

--PROFITABILIRY

1~10

6

--LIQUIDITY

1~10

6

--LEVERAGE

1~10

5

--RESERVES

1~10

7

--CREDIT LINES

1~10

6

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

50

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.